Jubilant ingrevia
#jubilantingrea
Equirus initiates with target of 1,013rs
Expects the specialty chem to drive the growth
Lowest cost producer of pyridine derivatives with 20-80% mkt share
Nutrition n health science to grow steadily
Big volume growth expctd
Capex beneficiary

More from Shreenidhi P
First interview of Hiral Chandrana
#MASTEK
Adding 40+ customers every quarter from an year
650+ active clients
Met 150+ customers/partners virtually in last 40days
Focus to accelerate US growth-have strategy in place
960cr cash on books
Looking for organic+inorganic growth
#MASTEK
Adding 40+ customers every quarter from an year
650+ active clients
Met 150+ customers/partners virtually in last 40days
Focus to accelerate US growth-have strategy in place
960cr cash on books
Looking for organic+inorganic growth
#CNBCTV18Exclusive | Catch @_anujsinghal, @_soniashenoy & @SurabhiUpadhyay in conversation with @HiralChandrana who was appointed as global CEO of #Mastek last month. He says that a big part of their strategy is to grow in the US. @Reematendulkar pic.twitter.com/nRnfGoGHTp
— CNBC-TV18 (@CNBCTV18News) August 18, 2021